114 related articles for article (PubMed ID: 7479230)
21. Hypothermia following chemotherapy for Hodgkin's disease.
Weens JH; Hernandez B
Cancer Treat Rep; 1986 Feb; 70(2):313-4. PubMed ID: 3948197
[No Abstract] [Full Text] [Related]
22. High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.
Salar A; Martino R; Perea G; Ribera JM; López-Guillermo A; Guardia R; Escoda L; Altés A; Sierra J; Montserrat E
Haematologica; 2002 Oct; 87(10):1028-35. PubMed ID: 12368156
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of platidiam in the chemotherapy of lymphogranulomatosis and lymphosarcoma].
Korol'chuk LV; Kruglova GV
Ter Arkh; 1987; 59(6):37-40. PubMed ID: 3307012
[No Abstract] [Full Text] [Related]
25. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation.
Press OW; Livingston R; Mortimer J; Collins C; Appelbaum F
J Clin Oncol; 1991 Mar; 9(3):423-31. PubMed ID: 1999711
[TBL] [Abstract][Full Text] [Related]
26. Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
Chemioterapia; 1987 Jun; 6(2 Suppl):721-3. PubMed ID: 3509941
[No Abstract] [Full Text] [Related]
27. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
28. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY.
Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA
Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].
Li YH; Jiang WQ; Huang HQ; Zhang L; Liu DG; Xu RH; Zhou ZM; Sun XF; Lin TY; Xu GC; He YJ; Guang ZZ
Ai Zheng; 2002 Aug; 21(8):900-2. PubMed ID: 12478903
[TBL] [Abstract][Full Text] [Related]
30. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
Sampi K; Maseki N; Sakurai M; Hattori M
Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
[No Abstract] [Full Text] [Related]
31. [High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Tobinai K
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1724-30. PubMed ID: 7574802
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
Philip T; Guglielmi C; Hagenbeek A; Somers R; Van der Lelie H; Bron D; Sonneveld P; Gisselbrecht C; Cahn JY; Harousseau JL
N Engl J Med; 1995 Dec; 333(23):1540-5. PubMed ID: 7477169
[TBL] [Abstract][Full Text] [Related]
33. ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.
Tempescul A; Ianotto JC; Eveillard JR; Guillerm G; Berthou C
Ann Hematol; 2011 Aug; 90(8):971-3. PubMed ID: 21057951
[No Abstract] [Full Text] [Related]
34. Hypothermia and Hodgkin's disease: case report and review of the literature.
Meert AP; Berghmans T; Sculier JP
Acta Clin Belg; 2006; 61(5):252-4. PubMed ID: 17240740
[TBL] [Abstract][Full Text] [Related]
35. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
Seropian S; Nadkarni R; Jillella AP; Salloum E; Burtness B; Hu GL; Zelterman D; Cooper DL
Bone Marrow Transplant; 1999 Mar; 23(6):599-605. PubMed ID: 10217191
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
Oguro M; Takagi T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):508-15. PubMed ID: 6764108
[TBL] [Abstract][Full Text] [Related]
37. [Lyposomal form of doxorubicin hydrochloride lypodox in the treatment of lymphogranulomatosis and non-Hodgkin's lymphomas].
Ponamareva OV; Kindzel'skiĭ LP; Kulik GI
Lik Sprava; 2001; (1):112-7. PubMed ID: 15311711
[TBL] [Abstract][Full Text] [Related]
38. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
[No Abstract] [Full Text] [Related]
39. Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
Dantas AA; Manhani AR; Coutinho F; Del Giglio A
Acta Haematol; 2006; 116(4):275-8. PubMed ID: 17119330
[No Abstract] [Full Text] [Related]
40. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.
Brice P; Marolleau JP; Dombret H; Lepage E; Baruchel A; Adam M; Miclea JM; Sitthy X; Gisselbrecht C
Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
